Patents Assigned to Johnson & Johnson
  • Patent number: 11832883
    Abstract: A system includes a processor and a display. The processor is configured to: (a) receive, from a camera inserted into an eye of a patient, at least an optical image of at least a region-of-interest (ROI) of the eye, (b) receive, from a position tracking system (PTS), a position signal indicative of a position of a medical instrument treating the eye, (c) register the optical image and the PTS in a common coordinate system, and (d) estimate the position of the medical instrument in the optical image. The display is configured to visualize at least the ROI and the medical instrument.
    Type: Grant
    Filed: April 23, 2020
    Date of Patent: December 5, 2023
    Assignee: JOHNSON & JOHNSON SURGICAL VISION, INC.
    Inventors: Assaf Govari, Vadim Gliner
  • Patent number: 11834547
    Abstract: Provided are ophthalmic devices comprised of a reaction product of a composition comprising: (i) a crosslinked substrate network containing covalently bound activatable free radical initiators; and (ii) a grafting composition containing one or more ethylenically unsaturated compounds. Also provided are processes for making ophthalmic devices.
    Type: Grant
    Filed: February 25, 2021
    Date of Patent: December 5, 2023
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Brian Aitken, Charles Scales, Scott Joslin, Yong Zhang, Dola Sinha, Shivkumar Mahadevan, Patricia Martin, Fang Lu, Donnie Duis, Stephen C. Arnold
  • Patent number: 11833114
    Abstract: A cleansing composition and method of using a cleansing composition, the cleansing composition including a blend of three different emollients, the emollients including a first stearic ester, a second stearic ester, and a branched hydrocarbon, where the first stearic ester and second stearic ester are different from each other.
    Type: Grant
    Filed: October 19, 2022
    Date of Patent: December 5, 2023
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Jasmin Figueroa, Diana Johnson, Marcee Martinez, Abhijit Bidaye, Farahdia Edouard
  • Patent number: 11828913
    Abstract: Described are silicone hydrogels that are more biocompatible than current ocular materials. The silicone hydrogels are formed from a reactive monomer mixture comprising: a mixture of hydroxyl substituted silicone containing components, at least one polyamide; and at least one hydrophilic monomer. The silicone hydrogels also display a desirable balance of properties, including clarity, oxygen permeability, wettability and desirable protein uptake.
    Type: Grant
    Filed: November 19, 2020
    Date of Patent: November 28, 2023
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Azaam Alli, Alexander Guzman
  • Patent number: 11827755
    Abstract: Described is a silicone hydrogel contact lens having non-uniform morphology. The contact lens may be made from a reactive mixture comprising: a silicone-containing component; a hydrophilic component; a non-reactive polymeric internal wetting agent; and a polymerization initiator, the contact lens having an oxygen permeability of at least about 60 barrers, and wherein the molar ratio in the lens of the polymeric non-reactive internal wetting agent to silicone, without a surface treatment, is greater in the lens's surface than in its bulk.
    Type: Grant
    Filed: December 13, 2022
    Date of Patent: November 28, 2023
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Azaam Alli, Donald E. Riederer, Alexander Guzman, Bernardo Santa Maria
  • Patent number: 11829008
    Abstract: A molded contact lens comprising a stiffer optic zone relative to the peripheral zone of the contact lens provides an optical element for correcting astigmatism without the need for or substantially minimizing the need for the correction of rotational misalignment. The higher elastic modulus optic zone vaults over the cornea thereby allowing a tear lens to form. The tear lens follows or assumes the shape of the back surface of the contact lens. The combination of the tear lens and the optical zone provide an optical element for correction of refractive error.
    Type: Grant
    Filed: October 19, 2021
    Date of Patent: November 28, 2023
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Azaam Alli, Dola Sinha
  • Patent number: 11820899
    Abstract: Described are polymerizable high energy light absorbing compounds. The compounds absorb various wavelengths of ultraviolet and/or high energy visible light and are suitable for incorporation in various products, such as biomedical devices and ophthalmic devices.
    Type: Grant
    Filed: December 3, 2020
    Date of Patent: November 21, 2023
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Shivkumar Mahadevan, Dawn D. Wright
  • Patent number: 11822153
    Abstract: Described herein are systems and/or methods for forming an ophthalmic lens. An example method may comprise a step of determining a power profile based on a power profile function defined by a base optical power, an amount of spherical aberration at a radial distance from a geometric center of the lens, and a bump function. The example method may comprise a step of adjusting the power profile based at least on minimizing a shape metric of a through-focus curve.
    Type: Grant
    Filed: September 28, 2020
    Date of Patent: November 21, 2023
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Xin Wei, Philippe F Jubin, Derek Nankivil, Minghan Chen, Gregory Williby
  • Patent number: 11819384
    Abstract: The present invention is directed to a flowable hemostatic paste comprising a crosslinked carboxymethyl cellulose and at least one non-toxic dispersant. More specifically the present invention relates to a hemostatic paste containing citric acid cross-linked CMC, which is suspended or dispersed as a powder in a mixture of a first non-toxic glycerol-containing hygroscopic dispersant and a second non-toxic alcohol functionalized dispersant comprising propylene glycol or 1,3-butanediol.
    Type: Grant
    Filed: March 21, 2022
    Date of Patent: November 21, 2023
    Assignees: Guangzhou Bioseal Co., Ltd., Johnson & Johnson China Ltd., Ethicon, Inc.
    Inventors: Dengmin Feng, Ling Teng, Yanhui Zhang, Guojun Ni, Yufu Li, Xiang Wan
  • Patent number: 11820729
    Abstract: Provided are compounds described by the Formula I: wherein: R1 is a linear or branched, saturated or unsaturated aliphatic group having from 5 to 22 carbon atoms; R2 is selected from the group consisting of the functional groups: —NH2; and salts thereof; n is from 0 to 4; and R3 is a linear or branched, saturated or unsaturated aliphatic group having from 1 to 6 carbon atoms. Also provided are compositions comprising, and methods of use of, the compounds of the present invention.
    Type: Grant
    Filed: June 3, 2021
    Date of Patent: November 21, 2023
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Robert J. Gambogi, Anthony R. Geonnotti, III, Michael C. Giano, Latrisha Petersen
  • Patent number: 11820850
    Abstract: Provided are polymer compositions made by a process comprising: (a) providing a first reactive composition containing: (i) a polymerization initiator that is capable, upon a first activation, of forming two or more free radical groups, at least one of which is further activatable by subsequent activation; (ii) one or more ethylenically unsaturated compounds; and (iii) a crosslinker; (b) subjecting the first reactive composition to a first activation step such that the first reactive composition polymerizes therein to form a crosslinked substrate network containing a covalently bound activatable free radical initiator, (c) combining the crosslinked substrate network with a second reactive composition containing one or more ethylenically unsaturated compounds; and (d) activating the covalently bound activatable free radical initiator of the crosslinked substrate network such that the second reactive composition polymerizes therein with the crosslinked substrate network to form a grafted polymeric network and a
    Type: Grant
    Filed: April 28, 2021
    Date of Patent: November 21, 2023
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Brian Aitken, Charles Scales, Scott Joslin, Yong Zhang, Dola Sinha, Shivkumar Mahadevan, Patricia Martin, Fang Lu, Donnie Duis, Stephen C. Arnold
  • Patent number: 11806465
    Abstract: In one embodiment, an irrigated medical system includes a medical tool, an irrigation line configured to fluidically connect an irrigation reservoir storing irrigation fluid to the medical tool, and provide at least some of the irrigation fluid to the medical tool, a force sensor configured to be coupled with the irrigation reservoir, and provide a signal responsively to a force exerted by the irrigation reservoir on the force sensor over time as irrigation fluid in the irrigation reservoir is depleted, and a controller configured to find an irrigation rate of the irrigation fluid flowing in the irrigation line responsively to the signal.
    Type: Grant
    Filed: June 24, 2021
    Date of Patent: November 7, 2023
    Assignee: JOHNSON & JOHNSON SURGICAL VISION, INC.
    Inventors: Assaf Govari, Eran Aharon
  • Patent number: D1004435
    Type: Grant
    Filed: October 26, 2021
    Date of Patent: November 14, 2023
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Evan Rhodes, Thomas Joseph Zuber, Anthony Di Bitonto, Stephane Robic, Olivier Martins, Sul Gi Myoung
  • Patent number: D1004436
    Type: Grant
    Filed: October 26, 2021
    Date of Patent: November 14, 2023
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Evan Rhodes, Thomas Joseph Zuber, Anthony Di Bitonto, Stephane Robic, Olivier Martins, Sul Gi Myoung
  • Patent number: D1004437
    Type: Grant
    Filed: October 26, 2021
    Date of Patent: November 14, 2023
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Evan Rhodes, Thomas Joseph Zuber, Anthony Di Bitonto, Stephane Robic, Olivier Martins, Sul Gi Myoung
  • Patent number: D1005110
    Type: Grant
    Filed: October 6, 2021
    Date of Patent: November 21, 2023
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Melinda Brechbuehler, Cassandra Cobgill, Anthony Di Bitonto, Olivier Martins, Stephane Robic, Thomas Joseph Anthony Zuber, Evan Rhodes
  • Patent number: D1005111
    Type: Grant
    Filed: October 6, 2021
    Date of Patent: November 21, 2023
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Melinda Brechbuehler, Cassandra Cobgill, Anthony Di Bitonto, Olivier Martins, Stephane Robic, Thomas Joseph Anthony Zuber, Evan Rhodes
  • Patent number: D1005112
    Type: Grant
    Filed: October 15, 2021
    Date of Patent: November 21, 2023
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Evan Rhodes, Thomas Joseph Zuber, Anthony Di Bitonto, Stephane Robic, Olivier Martins
  • Patent number: D1005118
    Type: Grant
    Filed: October 15, 2021
    Date of Patent: November 21, 2023
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Evan Rhodes, Thomas Joseph Zuber, Anthony Di Bitonto, Stephane Robic, Olivier Martins
  • Patent number: D1005850
    Type: Grant
    Filed: October 6, 2021
    Date of Patent: November 28, 2023
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Melinda Brechbuehler, Cassandra Cobgill, Anthony Di Bitonto, Olivier Martins, Stephane Robic, Thomas Joseph Anthony Zuber, Evan Rhodes